NasdaqCM - Delayed Quote USD
XTL Biopharmaceuticals Ltd. (XTLB)
1.2000
0.0000
(0.00%)
At close: June 12 at 4:00:00 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
8,550
2,426
4,186
6,618
Total Liabilities Net Minority Interest
3,115
206
187
1,285
Total Equity Gross Minority Interest
5,435
2,220
3,999
5,333
Total Capitalization
5,435
2,220
3,999
5,333
Common Stock Equity
5,435
2,220
3,999
5,333
Net Tangible Assets
-1,574
1,840
3,619
4,953
Working Capital
-867
1,840
3,619
6,006
Invested Capital
5,573
2,220
3,999
5,333
Tangible Book Value
-1,574
1,840
3,619
4,953
Total Debt
138
--
--
--
Share Issued
881,385.1760
544,906.1490
544,906.1490
544,906.1490
Ordinary Shares Number
881,385.1760
544,906.1490
544,906.1490
544,906.1490
12/31/2021 - 9/1/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BT3.BE Lineage Cell Therapeutics Inc
0.5850
-0.85%
GXE.F Galapagos NV
24.40
-1.37%
ITRX inTerra Resources Corp
0.0240
0.00%
GENSY Genus plc
24.34
0.00%
8QQ.BE AbCellera Biologics Inc
2.5800
-6.99%
AB3A.MU Sarepta Therapeutics Inc
31.60
-1.86%
ADXS Ayala Pharmaceuticals, Inc.
0.0316
-5.82%
AYJ.HA Valneva SE
2.6880
-1.54%
300759.SZ Pharmaron Beijing Co., Ltd.
24.84
-2.47%
ONCIN.OL Oncoinvent ASA
2.0250
0.00%